Advanced search
Start date
Betweenand
Related content

GLYCOCORTICOID SENSITIVITY AND ITS RELATIONSHIP WITH THE COMPONENTS OF THE METABOLIC SYNDROME IN PATIENTS TREATED FOR CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA

Grant number: 18/21342-0
Support type:Regular Research Grants
Duration: March 01, 2019 - April 30, 2022
Field of knowledge:Health Sciences - Medicine - Maternal and Child Health
Principal researcher:Adriana Aparecida Siviero Miachon
Grantee:Adriana Aparecida Siviero Miachon
Home Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil
Assoc. researchers: ANA VIRGINIA LOPES DE SOUSA ; Angela Maria Spinola Castro ; Antonio de Miranda ; Carlos Alberto Longui ; Eunice Mayumi Suenaga

Abstract

In patients treated for childhood acute lymphocytic leukemia (ALL), the aim is to determine the components of the metabolic syndrome, including central obesity, lipids, blood pressure and glucose/insulin, to assess glucocorticoid (GC) sensitivity through sensitivity tests and in vitro measurements to evaluate polymorphic variants/isoforms of the GC receptor (GR) and and to correlate clinical and metabolic profiles with GC sensitivity. The proposal is to evaluate 40 patients treated for childhood ALL, both post-pubertal and at least two years out of therapy, according to clinical, disease-related and treatment characteristics, anthropometric variables (weight, height and body mass index), adiposity indexes (circumferences and their relationships, fat mass by dual energy X-ray absorptiometry and abdominal fat by abdominal tomography), endocrine-metabolic profile (lipids and insulin resistance), tests (0.25 mg overnight oral dexamethasone suppression test and very low dose intravenous dexamethasone suppression test), determination of polymorphic variants of GR and mRNA quantification of its GR-alpha processing variant by quantitative real-time polymerase chain reaction (qrt-PCR). It is known that GC sensitivity determined by mRNA expression of different isoforms and/or the presence of specific GR polymorphisms is one of the factors involved in the response to treatment and an important prognostic factor in ALL. It is speculated if it also represents a mechanism of increased risk for cardiovascular disease in this subgroup of patients. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list by writing to: cdi@fapesp.br.